Recylex S.A EV/EBIT
Cos'è EV/EBIT di Recylex S.A?
EV/EBIT di Recylex S.A. è 0.99
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Materials settore su EURONEXT rispetto a Recylex S.A
Cosa fa Recylex S.A?
Recylex S.A. recycles lead and plastic in France. It engages in the collection and recycling of used lead-acid batteries to recover lead and plastics materials. The company is also involved in zinc recycling and production business. In addition, the company engages in polypropylene recycling and compounds. Recylex S.A. was incorporated in 1988 and is headquartered in Suresnes, France.
Aziende con ev/ebit simili a Recylex S.A
- China Green Agriculture Inc ha EV/EBIT di 0.93
- Future FinTech Inc ha EV/EBIT di 0.94
- Steel Connect Inc ha EV/EBIT di 0.95
- Concurrent Computer ha EV/EBIT di 0.95
- Controladora Vuela Cia De Aviacion ha EV/EBIT di 0.98
- Canfor ha EV/EBIT di 0.99
- Recylex S.A ha EV/EBIT di 0.99
- Imunon Inc ha EV/EBIT di 1.00
- STM Plc ha EV/EBIT di 1.00
- A.P. Moller - Marsk A/S ha EV/EBIT di 1.00
- SandRidge Permian Trust ha EV/EBIT di 1.00
- Inozyme Pharma ha EV/EBIT di 1.01
- Interpace Biosciences Inc ha EV/EBIT di 1.01